MINI SHORT - BAYER | Market Closed - Deutsche Boerse AG 18:27:30 31/05/2024 BST | ||
| 4.96 EUR | -.--% |
|
| 1 month | -1.59% | ||
| 3 months | -0.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
Latest news about BAYER AG
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 4.96 | -.--% |
| 30/05/24 | 4.96 | -1.98% |
| 29/05/24 | 5.06 | +1.40% |
| 28/05/24 | 4.99 | +1.01% |
| 27/05/24 | 4.94 | -1.40% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 06:27 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BAYER AG |
| Issuer | 
Citi
|
| WKN | KA7QA4 |
| ISIN | DE000KA7QA49 |
| Date issued | 30/12/2019 |
| Strike | 77.98 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.64 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.34 € |
|---|---|
| Lowest since issue | 1.58 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.24
EUR
Average target price
36.64
EUR
Spread / Average Target
+29.73%
- Stock Market
- Certificates
- Certificat